Details of the Drug

General Information of Drug (ID: DM450I4)

• Drug Name: AL-02

Indication

Disease Entry	ICD 11	Status	REF
Amyotrophic lateral sclerosis	8B60.0	Phase 3	[1]

• Cross-matching ID: TTD ID: D0H1FN

References

• [1] ClinicalTrials.gov (NCT00069186) Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis. U.S. National Institutes of Health.